A group of researchers in the lab of Prof. Lucía Chávez Gutiérrez (VIB-KU Leuven) have unraveled the genetic contributions to familial Alzheimer's Disease development and revealed how specific ...

An experimental drug has shown promise in preventing Alzheimer’s for people at higher risk of developing the disease. That’s according to a new study from Washington University School of ...

Lucía Chávez Gutiérrez (VIB-KU Leuven) has unraveled the genetic contributions ... specific kinds of mutations and the age of onset for familial Alzheimer's disease could be useful for doctors ...

This inherited form of the disease tends to strike early—often before the age of 65—and is caused by mutations ... profile could delay the age of onset in familial Alzheimer’s disease ...

Genetics has been the steering force in establishing the biological framework for Alzheimer's disease research. At the end of ...

Lucía Chávez Gutiérrez (VIB-KU Leuven) have unraveled the genetic contributions ... specific kinds of mutations and the age of onset for familial Alzheimer’s disease could be useful for ...

Mutations in the PS1 gene are responsible for the most aggressive form of AD and account for 18-50% of all early-onset AD cases. [4] PS1 mutations are mainly missense substitutions that are ...

Low-dose interleukin-2 as an add-on therapy to riluzole (Rilutek) led to a non-significant reduction in mortality in an ...

Fundraising efforts have helped jump-start gene therapy that could help patients regardless of mutation ... despite all my best efforts to delay it,” Kramer-Golinkoff said.

Fundraising efforts have helped jump-start gene therapy that could help patients regardless of mutation ... despite all my best efforts to delay it," Kramer-Golinkoff said. Before her illness ...

Fundraising efforts have helped jump-start gene therapy that could help patients regardless of mutation ... despite all my best efforts to delay it,” Kramer-Golinkoff said.